BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37126595)

  • 21. Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.
    El-Chemaly S; Pacheco-Rodriguez G; Ikeda Y; Malide D; Moss J
    Lymphat Res Biol; 2009 Dec; 7(4):197-203. PubMed ID: 20143918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic Approaches.
    Akram KM; Patel N; Spiteri MA; Forsyth NR
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26797607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell senescence and fibrotic lung diseases.
    Liu RM; Liu G
    Exp Gerontol; 2020 Apr; 132():110836. PubMed ID: 31958492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis.
    Ota C; Ng-Blichfeldt JP; Korfei M; Alsafadi HN; Lehmann M; Skronska-Wasek W; M De Santis M; Guenther A; Wagner DE; Königshoff M
    Sci Rep; 2018 Aug; 8(1):12983. PubMed ID: 30154568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolving role of the lung microbiome in pulmonary fibrosis.
    Lipinski JH; Moore BB; O'Dwyer DN
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L675-L682. PubMed ID: 32877221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
    Williamson JD; Sadofsky LR; Hart SP
    Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
    Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
    PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis.
    Warren R; Lyu H; Klinkhammer K; De Langhe SP
    Elife; 2023 May; 12():. PubMed ID: 37166104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice.
    Liang J; Zhang Y; Xie T; Liu N; Chen H; Geng Y; Kurkciyan A; Mena JM; Stripp BR; Jiang D; Noble PW
    Nat Med; 2016 Nov; 22(11):1285-1293. PubMed ID: 27694932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis.
    Tzouvelekis A; Aidinis V; Harokopos V; Karameris A; Zacharis G; Mikroulis D; Konstantinou F; Steiropoulos P; Sotiriou I; Froudarakis M; Pneumatikos I; Tringidou R; Bouros D
    Respir Res; 2009 Feb; 10(1):14. PubMed ID: 19250543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.
    Thachil J
    Med Hypotheses; 2009 Mar; 72(3):291-3. PubMed ID: 19036527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis.
    Fernandez IE; Eickelberg O
    Lancet; 2012 Aug; 380(9842):680-8. PubMed ID: 22901889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
    J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New mechanisms of pulmonary fibrosis.
    Strieter RM; Mehrad B
    Chest; 2009 Nov; 136(5):1364-1370. PubMed ID: 19892675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary fibrosis: patterns and perpetrators.
    Noble PW; Barkauskas CE; Jiang D
    J Clin Invest; 2012 Aug; 122(8):2756-62. PubMed ID: 22850886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis.
    Ohta H; Chiba S; Ebina M; Furuse M; Nukiwa T
    Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L193-205. PubMed ID: 22003091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs in idiopathic pulmonary fibrosis.
    Pandit KV; Milosevic J; Kaminski N
    Transl Res; 2011 Apr; 157(4):191-9. PubMed ID: 21420029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.
    Rose JA; Planchart Ferretto MA; Maeda AH; Perez Garcia MF; Carmichael NE; Gulati S; Rice MB; Goldberg HJ; Putman RK; Hatabu H; Raby BA; Rosas IO; Hunninghake GM
    Am J Respir Crit Care Med; 2023 Jan; 207(2):211-214. PubMed ID: 36099425
    [No Abstract]   [Full Text] [Related]  

  • 40. Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models.
    Désogère P; Tapias LF; Hariri LP; Rotile NJ; Rietz TA; Probst CK; Blasi F; Day H; Mino-Kenudson M; Weinreb P; Violette SM; Fuchs BC; Tager AM; Lanuti M; Caravan P
    Sci Transl Med; 2017 Apr; 9(384):. PubMed ID: 28381537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.